Sorafenib
From IDWiki
Revision as of 12:06, 24 November 2023 by Aidan (talk | contribs) (Created page with "* Multikinase inhibitor, targetting Raf kinase and possibly other kinase activation by VEGF 1, 2, and 3, PDGFRβ, FLT3, c-KIT and RET * Indications include renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid carcinoma, as well as certain types of acute myeloid leukemia * Can cause myelosuppression Category:Medications Category:Oncology")
- Multikinase inhibitor, targetting Raf kinase and possibly other kinase activation by VEGF 1, 2, and 3, PDGFRβ, FLT3, c-KIT and RET
- Indications include renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid carcinoma, as well as certain types of acute myeloid leukemia
- Can cause myelosuppression
